Amy L. Delson

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.

Rosalyn W. Sayaman, L. Esserman, N. Hylton, 2023, Cancer cell.

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.

L. Esserman, S. Shchegrova, Hsin-Ta Wu, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy.

E. Winer, T. Fehm, C. Hudis, 2020, Journal of the National Cancer Institute.